ILIUM DEXAPENT ANTI-INFLAMMATORY & GLUCOGENIC STEROID INJECTION

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:

DEXAMETHASONE SODIUM PHOSPHATE

Available from:

TROY LABORATORIES PTY LTD

INN (International Name):

dexamethasone sodium phosphate(5mg/mL)

Pharmaceutical form:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composition:

DEXAMETHASONE SODIUM PHOSPHATE STEROID-GLUCOCORTICOID Active 5.0 mg/ml

Units in package:

50mL

Class:

VM - Veterinary Medicine

Manufactured by:

TROY LABORATORIES

Therapeutic group:

CATTLE | HORSE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COLT | COW | DAIRY COW | DONKEY |

Therapeutic area:

ENDOCRINE SYSTEM

Therapeutic indications:

CORTICOSTEROID | ADVANCING PARTURITION | ALLERGIC REACTIONS | ANTIADRENAL SUPPRESSION | ANTI-INFLAMMATORY | ANTISHOCK | ARTHRITIS | BRONCHITIS | CATABOLIC COMPLICATIONS | CHRONIC BRONCHITIS | CORTICOSTEROIDS | CORTICOSTEROIDS AND RELATE | COUGHS | DERMATITIS | DERMATOLOGICAL DISORDERS | DERMATOSES | ECZEMA | GLUCOGENIC STEROID | JOINT DISEASE | KETOSIS | LOCOMOTIVE DISEASES | MUSCULO SKELETAL INFLAMMAT | ORTHOPAEDIC | PARTURIENT UDDER OEDEMA | PARTURITION | PRURITIS | RESPIRATORY TRACT DISEASES | RHEUMATIC DISEASES | STRESS | TOXAEMIA | WATER RETENTION

Product summary:

Poison schedule: 4; Withholding period: WHP: Milk:Milk collected from cows wit hin 72 hours following treatment MUST N OT BE USED for human consumption or pro cessing.This milk should not be fed to bobby calves. Meat-Do not use less than 10 days before slaughter for human con sumption. TRADE ADVICE: EXPORT SLAUGHTE R INTERVAL (ESI): This product does not have an ESI established. For advice on the ESI, contact the manufacturer on ( 02) 9604 6266 before using this product .; Host/pest details: CATTLE: [CORTICOSTEROID]; HORSE: [CORTICOSTEROID]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [CORTICOSTEROID]; HORSE: [CORTICOSTEROID]; Anti-inflammatory and glucogenic steroid injection for use in horses and cattle.This product may induce parturition in mares. Milk from treated cows should not be fed to bobby calves.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

                                19 Nov 2010
ILIUM DEXAPENT INJECTION
PRIMARY LABEL
______________________________________________________________________
_ _
_Main panel – carton draft_
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM DEXAPENT
ANTI-INFLAMMATORY & GLUCOGENIC
STEROID INJECTION
ACTIVE CONSTITUENT:
5 mg/mL DEXAMETHASONE SODIUM PHOSPHATE
ILIUM
50mL
_ _
_Ancillary panel: _
_ _
Anti-inflammatory and glucogenic steroid injection for use in horses
and cattle.
DIRECTIONS FOR USE:
THIS PRODUCT MAY INDUCE PARTURITION IN MARES.
DOSAGE AND ADMINISTRATION:
Use the contents within 24 hours of first broaching of the vial.
Discard the unused
portion
HORSES AND CATTLE:
10-30 mg, i.m. or i.v.
REPEAT EVERY 12 TO 24 hours.
WITHHOLDING PERIODS:
MILK:
MILK COLLECTED FROM COWS WITHIN 72 HOURS FOLLOWING TREATMENT
MUST NOT BE USED FOR HUMAN CONSUMPTION OR PROCESSING.
THIS MILK SHOULD NOT BE FED TO BOBBY CALVES.
MEAT:
DO NOT USE LESS THAN 10 DAYS BEFORE SLAUGHTER FOR HUMAN
CONSUMPTION.
TRADE ADVICE:
EXPORT SLAUGHTER INTERVAL (ESI): This product does not have an ESI
established. For advice on the ESI, contact the manufacturer on (02)
9604 6266
before using this product.
FIRST AID: If poisoning occurs, contact a doctor or Poisons
Information Centre.
_Phone Australia 131126 _
TROY LABORATORIES PTY. LIMITED
31-35 GLENDENNING ROAD, GLENDENNING NSW 2761 AUSTRALIA
website: www.troylab.com.au
email: info@troylab.com.au
Dispose of empty container by wrapping with paper and putting in the
garbage.
Store below 30

C (Room Temperature). Protect from light.
APVMA Approval No. 50583/50399
Batch:
Expiry:
Version: V02
Page 1 of 1 RLP APPROVED
Info
PEST

Verified
19 Nov 2010
ILIUM DEXAPENT INJECTION
IMMEDIATE LABEL
______________________________________________________________________
_ _
_Main panel – vial draft _
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
ILIUM DEXAPENT
ANTI-INFLAMMATORY & GLUCOGENIC
STEROID INJECTION
ACTIVE CONSTITUENT:
5 mg/mL DEXAMETHASONE SODIUM PHOSPHATE
ILIUM
5
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ILIUM DEXAPENT ANTI-INFLAMMATORY & GLUCOGENIC STEROID
INJECTION
PAGE: 1 OF 4
THIS REVISION ISSUED: JULY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: 02 9677 9000
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
(02)9677 9000
31-35 GLENDENNING ROAD
FAX:
(02) 9677 9300
GLENDENNING NSW 2761
CHEMICAL NATURE:
Water solution of ingredients.
TRADE NAME:
ILIUM DEXAPENT ANTI-INFLAMMATORY & GLUCOGENIC STEROID INJECTION
PRODUCT CODE:
50583
PRODUCT USE:
Anti-inflammatory and glucogenic steroid injection for use in horses
and cattle.
CREATION DATE:
JULY, 2005
THIS VERSION ISSUED:
JULY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, colourless liquid.
ODOUR:
Very faint, characteristic odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
This is a pharmacologically active preparation, and contact should be
avoided except for its intended veterinary use.
INHALATION
SHORT TERM EXPOSURE:
Significant inhalation exposure is considered to be unlikely.
Available data indicates that
this product is not harmful. In addition product is unlikely to cause
any discomfort or irritation.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data
                                
                                Read the complete document